These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33203681)

  • 1. Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
    Zeng HL; Dichio V; Rodríguez Horta E; Thorell K; Aurell E
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31519-31526. PubMed ID: 33203681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of SARS-CoV-2 Genomes from West Java, Indonesia.
    Fibriani A; Stephanie R; Alfiantie AA; Siregar ALF; Pradani GAP; Yamahoki N; Purba WS; Alamanda CNC; Rahmawati E; Rachman RW; Robiani R; Ristandi RB
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mutations in SARS-CoV-2 associate with severe and mild outcome.
    Nagy Á; Pongor S; Győrffy B
    Int J Antimicrob Agents; 2021 Feb; 57(2):106272. PubMed ID: 33347989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
    Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH
    Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study.
    Colson P; Levasseur A; Gautret P; Fenollar F; Thuan Hoang V; Delerce J; Bitam I; Saile R; Maaloum M; Padane A; Bedotto M; Brechard L; Bossi V; Ben Khedher M; Chaudet H; Million M; Tissot-Dupont H; Lagier JC; Mboup S; Fournier PE; Raoult D
    Travel Med Infect Dis; 2021; 40():101980. PubMed ID: 33535105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes.
    Cao C; He L; Tian Y; Qin Y; Sun H; Ding W; Gui L; Wu P
    Infect Genet Evol; 2021 Aug; 92():104831. PubMed ID: 33798758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus.
    Roy C; Mandal SM; Mondal SK; Mukherjee S; Mapder T; Ghosh W; Chakraborty R
    Genomics; 2020 Nov; 112(6):5331-5342. PubMed ID: 33161087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates.
    Prathiviraj R; Chellapandi P; Begum A; Kiran GS; Selvin J
    Virus Res; 2022 Jan; 307():198618. PubMed ID: 34740719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
    Baddock HT; Brolih S; Yosaatmadja Y; Ratnaweera M; Bielinski M; Swift LP; Cruz-Migoni A; Fan H; Keown JR; Walker AP; Morris GM; Grimes JM; Fodor E; Schofield CJ; Gileadi O; McHugh PJ
    Nucleic Acids Res; 2022 Feb; 50(3):1484-1500. PubMed ID: 35037045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
    Yan L; Yang Y; Li M; Zhang Y; Zheng L; Ge J; Huang YC; Liu Z; Wang T; Gao S; Zhang R; Huang YY; Guddat LW; Gao Y; Rao Z; Lou Z
    Cell; 2021 Jun; 184(13):3474-3485.e11. PubMed ID: 34143953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein.
    Pal A; Dobhal S; Dey KK; Sharma AK; Savani V; Negi VS
    Comput Biol Chem; 2021 Dec; 95():107594. PubMed ID: 34736125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.
    Liang F
    Viruses; 2023 May; 15(5):. PubMed ID: 37243278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target.
    Tahir M
    J Med Virol; 2021 Jul; 93(7):4258-4264. PubMed ID: 33837972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.